Davis Polk advised the representatives of the underwriters on the offering. Certain selling shareholders of I-Mab issued $177 million SEC-registered follow-on secondary offering of 3,283,950 American depositary...
I-Mab’s $177 Million ADSs Follow-on Secondary Offering
InnoCare Pharma Limited’s $287 Million Initial Public Offering
Davis Polk and Ogier advised InnoCare Pharma Limited on the deal. InnoCare Pharma Limited executed its initial public offering and listing on the Hong Kong Stock...